報價延遲最少15分鐘:2026/10/01 19:16 EDT
盤後時段
|
||||
|
17.19 
|
|
|
常規時段 (已結束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
17.02
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.95/-0.82
|
|
企業價值
1.12B
|
| 資產負債 |
|
每股賬面淨值
5.94
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
224.50M
|
|
每股收益
2.03
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S. |
